Cardiologist in profile: Dr Tau Boga 3 Nov 2010 0 comments Our new cartoonist Dr Tau Boga, a cardiologist who trained in Brisbane and Port Morsby, became a doctor because there was no astronaut training course in Papua New Guinea.
Home-based care reduces admissions 7 Oct 2010 0 comments A nurse-led home-based intervention can improve survival and reduce further hospitalisations in cardiac patients, research shows.
Review highlights distinct statin-induced myopathy 15 Sep 2010 0 comments Clinicians need to be aware of a rare immune-mediated necrotizing myopathy triggered by statins, a review of recent progress on statin myopathy concludes.
Anxiety disorders a 'strong beacon' for CHD 29 Jun 2010 0 comments New research that has firmly established anxiety as an independent predictor for subsequent coronary heart disease has prompted a psychiatrist to suggest that cardiologists ask their patients about…
High-dose corticosteroids overused in COPD 22 Jun 2010 0 comments Despite current guidelines recommending low-dose oral corticosteroids for the treatment of COPD exacerbations, clinicians are much more likely to use expensive, high-dose, intravenous corticosteroids…
Causal link found between triglyceride-mediated pathways and CHD 12 May 2010 0 comments Individuals with a polymorphism of the apolipoprotein A5 gene are at a significantly higher risk of coronary heart disease, new research shows.
High glycaemic carbs a risk for women 13 Apr 2010 0 comments A high consumption of carbohydrates from high-glycaemic foods appears to influence the risk of developing coronary heart disease in women, Italian researchers have found.
Moderate alcohol intake lowers mortality in CVD 30 Mar 2010 0 comments Patients with cardiovascular disease can be reassured that low to moderate alcohol consumption is not harmful to their health and is actually beneficial, a meta-analysis finds.
AF predicts mortality after CABG 30 Mar 2010 0 comments Patients with new-onset atrial fibrillation following a coronary artery bypass graft are at an increased risk of long-term mortality, research shows.
NAVIGATOR confirms lifestyle measures still best 15 Mar 2010 0 comments While progression to diabetes is slightly reduced by the ARB valsartan and not reduced by the short-acting insulin secretagogue nateglinide, neither drug reduces the rate of CV events in patients…
